Illiasul Ibad/X
Aug 24, 2025, 18:21
Illiasul Ibad: How Clinical Trials Revolutionized ANCA Vasculitis Treatment from Cyclophosphamide to Rituximab
Illiasul Ibad, Rheumatologist at Christian Medical College, Vellore, shared a post on X:
“How clinical trials revolutionized ANCA vasculitis maintenance – from cyclophosphamide to rituximab, this is the journey of evidence, one trial at a time.
Facts. Timelines. Game-changers.
A must-read for every physician, rheumatologist, nephrologist, pulmonologist, and ophthalmologist. This is how science shaped the standard of care.
Special thanks to George Deva Raja for the image design.”
Stay updated with Hemostasis Today.
-
Feb 27, 2026, 18:30Sanjeev Saksena: From Isolated Case Reports to Clinical Evidence for Post-Ablation Myocardial Ischemia
-
Feb 27, 2026, 18:21Priya Prasad: Can Money Buy Blood?
-
Feb 27, 2026, 18:19Trulee Cardona: Hemophilia Care in Uzbekistan and Why It Matters
-
Feb 27, 2026, 18:19Bartosz Hudzik: Do Elevated Lipoprotein(a) Levels Predict Long-Term Cardiovascular Risk in Otherwise Healthy Women?
-
Feb 27, 2026, 18:14Mohamed Sikkander Abdul Razak: Factor XIa Inhibitors Show Promise With Lower Bleeding Risk
-
Feb 27, 2026, 18:09Hariom Rajput: Early Recognition and Prevention of Deep Vein Thrombosis
-
Feb 27, 2026, 18:08Karen Fahey: What If the Blood Products You Rely On Weren’t Safe?
-
Feb 27, 2026, 17:46Perla Bandini: Whole-Exome Sequencing Unveils Suspected Primary Hemostasis Disorders
-
Feb 27, 2026, 17:44Ekaterina Balaian: Exploring Fostamatinib Use in APS Patients with Thrombocytopenia